Fingerprint
Dive into the research topics of 'A Bayesian phase I/II platform design for co-developing drug combination therapies for multiple indications'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A Bayesian phase I/II platform design for co-developing drug combination therapies for multiple indications
Rongji Mu, Jin Xu, Rui Tang, Scott Kopetz, Ying Yuan
Research output: Contribution to journal › Article › peer-review
2
Scopus
citations